INCLUSION~1. Is male or female, at 55-85 years of age (inclusive) at screening self-reported memory complaint,
corroborated by spouse or companion as appropriate.~2. Wechsler Memory Scale III (WMS-III) age-adjusted Logical
Memory II score ≤ 5.~3. Mini-Mental State Exam (MMSE) ≥23~4. Center for Epidemiologic Studies-Depression
(CES-D) score <27.~5. Normal thyroid function, defined as TSH, T3 and T4 within normal limits.~6. Agree not to
consume alcoholic beverages within 8 hours of each study visit.~7. Willing and able to sign informed consent
and complete the CTB and all other tests and procedures as listed in the protocol.~8. Able to read at a 6th
grade level or equivalent~9. Female subjects must be surgically sterile or post-menopausal for at least 2
years. If <2 years post-menopausal, then a follicle stimulating hormone (FSH) ≥40 mIU/mL must be obtained.~10.
If participant is receiving an acetylcholinesterase inhibitor or memantine, the dose must have been stable for
at least three months before Screening~11. Must have a reliable and competent trial partner/informant who has a
close relationship with the participant and is willing to accompany the participant to all required trial
visits, and to monitor compliance of the administration of the trial medication~
